靶向 FLT3 特异性 CAR-T 细胞治疗伴 KMT2A 重排的急性淋巴细胞白血病
Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement.
46.9分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement.
Current Landscape of Adoptive Cell Therapy and Challenge to Develop "Off-The-Shelf" Therapy for Hepatocellular Carcinoma.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。